Warner-Lambert Rezulin
Executive Summary
The most current information regarding Rezulin liver-related deaths and transplants released by the company covers the period through March 5. As of that date, Rezulin therapy was possibly or probably associated with 28 liver-related deaths, seven liver transplants and eight cases of encephalopathy. The May 31 issue of "The Pink Sheet" (p. 4) implied that those numbers remain unchanged. However, the company continues to evaluate information on Rezulin and has not publicly updated those figures